Bellicum Pharmaceuticals

Memory Pharmaceuticals

Memory Pharmaceuticals Corp. is a publicly traded (NASDAQ: MEMY) biopharmaceutical company focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.

Select Venture Capital & Financial Partners

Alta Partners HealthCare Ventures, L.L.C. MPM Capital Oxford Bioscience Partners Trivium Capital Management LLC Venrock